Journal club - Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation

Hugh Calkins
A John Camm

BACKGROUND: Catheter ablation is an antiarrhythmic surgical technique used in the treatment of atrial fibrillation. Typically, it is performed with uninterrupted anticoagulation with warfarin, or interruption of a NOAC course for a period before and following surgery. However, the results of this new study indicate that an uninterrupted course of NOACs may, in fact, be safer than other anticoagulant courses.

TARGET AUDIENCE: This educational activity is designed for cardiologists, surgeons, primary care physicians, GPs, nurses and any other healthcare professional with an interest or role in atrial fibrillation management.

LEARNING OBJECTIVE: Upon completion of this activity, participants should be able to:

  • Identify factors that influence the choice and dose of oral anticoagulant in atrial fibrillation patients scheduled to receive an ablation procedure.


Professor John Camm

Advisor for: Boehringer Ingelheim, Daiichi Sankyo

Consultant (retained) for: Boehringer Ingelheim

Received honoraria from: Bayer, Daiichi Sankyo, BMS-Pfizer

Dr Hugh Calkins

Consultant for: Boehringer Ingelheim, Medtronic

Received honoraria from: Boehringer Ingelheim

Received research support from: Boehringer Ingelheim

Staff and reviewer disclosures

ACHL staff, PCM Scientific staff, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and PCM Scientific. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Credit designation

The Academy for Continued Healthcare Learning designated this live activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This independent educational activity is supported by funding from Boehringer Ingelheim. PCM Scientific is the medical education company acting as scientific secretariat and organiser for this programme.

The activity is run at arm’s length from the financial supporter and all content is created by the faculty. No funder has had input into the content of the materials or presentations available on this website.

Visit the site here